Forest and Cypress Announce Submission of New Drug Application for … – FOX News

by General Manager on 5th January 2008

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News, Research

Forest and Cypress Announce Submission of New Drug Application for
FOX News - Dec 31, 2007
Milnacipran is jointly being developed for fibromyalgia syndrome in the United States market by Forest and its licensor, Cypress Bioscience,

Leave a Comment

Previous post: Fibromyalgia, the unknown disease! – Wilmington News Journal, OH

Next post: Chronic pain vexes patients, physicians – Arizona Republic